James E. Hosch
Direktor/Vorstandsmitglied bei Arrogene, Inc.
Profil
James E.
Hosch is currently a Director at Arrogene, Inc. He was previously a Managing Director at WestPark Capital, Inc. He obtained an undergraduate degree from Texas A&M University.
Aktive Positionen von James E. Hosch
| Unternehmen | Position | Beginn |
|---|---|---|
Arrogene, Inc.
 Arrogene, Inc. Pharmaceuticals: MajorHealth Technology Arrogene, Inc. commercializes a cancer treatment technology and a proprietary molecular delivery platform. Its technology delivers peptide, protein and oligonucleotide therapeutics across the blood-brain barrier to cancer cells to prevent tumor growth or for imaging. The company was founded by Julia Ljubimova, Alexander Ljubimova, Keith Black and Eggehard Holler in 2006 and is headquartered in Los Angeles, CA. | Direktor/Vorstandsmitglied | 13.05.2016 |
Ehemalige bekannte Positionen von James E. Hosch
| Unternehmen | Position | Ende |
|---|---|---|
WestPark Capital, Inc.
 WestPark Capital, Inc. Investment ManagersFinance WestPark Capital, Inc. (WPC) is a SEC-registered investment advisor headquartered in Los Angeles, California. The firm was founded by Richard Rappaport in 1999 and is a subsidiary of Westpark Capital Group LLC. WPC offers investment services to individual and institutional investors. | Portfolio Manager-Aktien | - |
Ausbildung von James E. Hosch
| Texas A&M University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
WestPark Capital, Inc.
WestPark Capital, Inc. Investment ManagersFinance WestPark Capital, Inc. (WPC) is a SEC-registered investment advisor headquartered in Los Angeles, California. The firm was founded by Richard Rappaport in 1999 and is a subsidiary of Westpark Capital Group LLC. WPC offers investment services to individual and institutional investors. | Finance |
Arrogene, Inc.
Arrogene, Inc. Pharmaceuticals: MajorHealth Technology Arrogene, Inc. commercializes a cancer treatment technology and a proprietary molecular delivery platform. Its technology delivers peptide, protein and oligonucleotide therapeutics across the blood-brain barrier to cancer cells to prevent tumor growth or for imaging. The company was founded by Julia Ljubimova, Alexander Ljubimova, Keith Black and Eggehard Holler in 2006 and is headquartered in Los Angeles, CA. | Health Technology |
